In failing human hearts, the down-regulation of ZO-1 matches diminished connexin 43 expression, suggesting ZO-1 is critical for gap junction plaque stability during myocardial remodeling.
Answers are grounded in this paper and cite their sources.
May link ZO-1 to gap junction instability in human HF; hypothesis-generating and should not yet change practice.
Focal disorganization of gap junctional distribution and down-regulation of the major gap junctional protein connexin 43 are typical features of myocardial remodelling in the failing human heart. Increasing evidence indicates that connexin 43 interacts with zonula-occludens-1 (ZO-1), and it has recently been shown that ZO-1 promotes the formation and growth of gap junctional plaques. In the present study, distribution patterns of ZO-1 and connexin 43 were studied in normal and in heart failure patients using double-label immunohistochemistry and confocal microscopy. ZO-1 was found to be co-localized with connexin 43 at intercalated disks. Importantly, in patients with heart failure due to dilated or ischaemic cardiomyopathy, areas of diminished connexin 43 expression were characterized by a markedly reduced ZO-1 staining. Based on these data it is concluded that in patients with heart failure, down-regulation of ZO-1 matches the diminished expression levels of connexin 43, suggesting that ZO-1 plays an important role in gap junction formation and gap junction plaque stability.
No takes yet. Share an insight, caveat, or question.
Sawa Kostin (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: